Pharmanutra S.p.A. (FRA:761)

Pharmanutra Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	546	523	542	601	730	364
Market Cap Growth	2.47%	-3.62%	-9.76%	-17.67%	100.53%	60.68%
Enterprise Value	545	523	552	595	710	350
Last Close Price	57.10	52.91	54.16	59.69	70.12	-
PE Ratio	31.32	31.47	42.26	39.94	53.01	25.87
PS Ratio	4.30	4.50	5.39	7.24	10.71	6.41
PB Ratio	8.27	8.40	9.97	11.80	16.19	9.65
P/TBV Ratio	13.11	12.79	16.38	19.87	18.30	11.18
P/FCF Ratio	52.42	32.16	-	-	47.32	35.98
P/OCF Ratio	37.82	25.50	44.85	34.41	35.76	30.85
EV/Sales Ratio	4.29	4.50	5.49	7.16	10.41	6.17
EV/EBITDA Ratio	17.23	17.29	21.72	24.56	36.76	23.19
EV/EBIT Ratio	19.36	19.11	24.00	25.78	38.78	24.71
EV/FCF Ratio	52.33	32.17	-	-	46.00	34.61
Debt / Equity Ratio	0.32	0.39	0.52	0.35	0.14	0.04
Debt / EBITDA Ratio	0.66	0.79	1.10	0.73	0.33	0.11
Debt / FCF Ratio	2.01	1.49	-	-	0.41	0.16
Asset Turnover	1.08	1.01	0.95	0.97	1.11	1.13
Inventory Turnover	6.81	7.53	7.76	10.13	15.13	16.15
Quick Ratio	1.60	1.95	1.70	1.96	3.08	3.39
Current Ratio	2.19	2.38	2.12	2.28	3.32	3.63
Return on Equity (ROE)	27.73%	28.39%	24.36%	31.34%	33.26%	42.73%
Return on Assets (ROA)	14.96%	14.88%	13.54%	16.82%	18.58%	17.61%
Return on Capital (ROIC)	20.67%	20.25%	19.05%	24.01%	25.18%	23.95%
Return on Capital Employed (ROCE)	31.80%	30.40%	27.20%	31.00%	33.50%	34.90%
Earnings Yield	3.19%	3.18%	2.37%	2.50%	1.89%	3.87%
FCF Yield	1.91%	3.11%	-0.21%	-1.45%	2.11%	2.78%
Dividend Yield	1.77%	1.89%	1.57%	1.34%	1.01%	-
Payout Ratio	54.97%	49.20%	60.11%	45.53%	47.10%	31.64%
Buyback Yield / Dilution	0.58%	0.61%	0.05%	0.09%	-	-
Total Shareholder Return	2.35%	2.50%	1.62%	1.43%	1.01%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.